Ovarian Cancer Genomic Research

The genes we're born with may increase our risk for cancer. A new technology called multigene panel testing simultaneously examines a number of different genes to look for potentially cancer-causing mutations, which can provide information to help people take action to prevent or stop cancer.

October 2014 Women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should receive genetic counseling and be offered genetic testing, even in the absence of a family history. Germline BRCA1 and BRCA2 mutations account for approximately 15% of invasive ovarian carcinomas, and a somewhat higher proportion of fallopian tube or peritoneal carcinomas [1,2,3].

Multiple types of genetic tests exist with the ability to test for one or more specific genetic mutations. Your health care provider will determine what type of testing is right for you, based on a variety of elements, including the known genes that have been identified as having a connection to ovarian cancer, as well as your family cancer history.

We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Skip Navigation Susan J. Ramus *, Honglin Song *, Ed Dicks *, Jonathan P.